Fabiano Angela, Bizzarri Ranieri, Zambito Ylenia
Department of Pharmacy, University of Pisa.
NEST, Istituto Nanoscienze CNR (CNR-NANO) and Scuola Normale Superiore, Pisa, Italy.
Int J Nanomedicine. 2017 Jan 16;12:633-643. doi: 10.2147/IJN.S121642. eCollection 2017.
A thermosensitive ophthalmic hydrogel (TSOH) - fluid at 4°C (instillation temperature), semisolid at 35°C (eye temperature), which coupled the dosing accuracy and administration ease of eyedrops with the increased ocular bioavailability of a hydrogel - was prepared by gelling a chitosan hydrochloride (ChHCl) solution (27.8 mg/mL) medicated with 1.25 mg/mL 5-fluorouracil (5-FU) with β-glycerophosphate 0.8 mg/mL. Polymer mixtures, where Ch was partially (10%, 15%, or 20%) replaced by quaternary ammonium-chitosan conjugates (QA-Ch) or thiolated derivatives thereof, were also used to modulate 5-FU-release properties of TSOH. Also, Ch-based nanoparticles (NPs; size after lyophilization and redispersion 341.5±15.2 nm, polydispersity 0.315±0.45, ζ-potential 10.21 mV) medicated with 1.25 mg/mL 5-FU prepared by ionotropic cross-linking of Ch with hyaluronan were introduced into TSOH. The 5-FU binding by TSOH polymers in the sol state was maximum with plain Ch (31.4%) and tended to decrease with increasing QA presence in polymer mixture. 5-FU release from TSOH with or without NPs was diffusion-controlled and linear in √t. The different TSOH polymers were compared on a diffusivity basis by comparing the slopes of √t plots. These showed a general decrease with NP-containing TSOH, which was the most marked with the TSOH, where Ch was 20% replaced by the derivative QA-Ch50. This formulation and that not containing NP were instilled in rabbits and the 5-FU transcorneal penetration was measured by analyzing the aqueous humor. Both TSOH solutions increased the area under the curve (0-8 hours) 3.5 times compared with the plain eyedrops, but maximum concentration for the NP-free TSOH was about 0.65 µg/mL, followed by a slow decline, while the NP-containing one showed a plateau (0.25-0.3 µg/mL) in a time interval of 0.5-7 hours. This is ascribed to the ability of this TSOH to control drug release to a zero order and that of NPs to be internalized by corneal cells.
制备了一种热敏性眼用水凝胶(TSOH),其在4℃(滴注温度)时为流体,在35℃(眼部温度)时为半固体,它兼具眼药水给药的准确性和便利性以及水凝胶提高的眼部生物利用度。通过将含有1.25mg/mL 5-氟尿嘧啶(5-FU)的27.8mg/mL盐酸壳聚糖(ChHCl)溶液与0.8mg/mLβ-甘油磷酸酯凝胶化来制备TSOH。还使用了聚合物混合物,其中壳聚糖(Ch)部分(10%、15%或20%)被季铵化壳聚糖共轭物(QA-Ch)或其硫醇化衍生物取代,以调节TSOH的5-FU释放特性。此外,将通过壳聚糖与透明质酸的离子交联制备的含有1.25mg/mL 5-FU的壳聚糖基纳米颗粒(NPs;冻干再分散后的尺寸为341.5±15.2nm,多分散性为0.315±0.45,ζ电位为10.21mV)引入TSOH中。TSOH聚合物在溶胶状态下对5-FU的结合量在纯壳聚糖时最大(31.4%),并随着聚合物混合物中QA含量的增加而趋于降低。含或不含NPs的TSOH中5-FU的释放受扩散控制且呈√t线性关系。通过比较√t图的斜率,在扩散率基础上对不同的TSOH聚合物进行了比较。结果表明,含NP的TSOH的扩散率普遍降低,其中壳聚糖被20%的衍生物QA-Ch50取代的TSOH最为明显。将该制剂和不含NP的制剂滴入兔眼,并通过分析房水来测量5-FU的角膜透过率。与普通眼药水相比,两种TSOH溶液均使曲线下面积(0 - 8小时)增加了3.5倍,但不含NP的TSOH的最大浓度约为0.65μg/mL,随后缓慢下降,而含NP的TSOH在0.5 - 7小时的时间间隔内呈现平台期(0.25 - 0.3μg/mL)。这归因于该TSOH控制药物释放至零级的能力以及NP被角膜细胞内化的能力。